{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T16:50:53Z","timestamp":1697907053120},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1980,12,1]],"date-time":"1980-12-01T00:00:00Z","timestamp":344476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[1980,12]]},"DOI":"10.1007\/bf02713713","type":"journal-article","created":{"date-parts":[[2007,10,3]],"date-time":"2007-10-03T06:45:06Z","timestamp":1191393906000},"page":"113-119","source":"Crossref","is-referenced-by-count":2,"title":["Primary pulmonary hypertension: Modern approaches to an old Problem"],"prefix":"10.1007","volume":"158","author":[{"given":"S.","family":"Fein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Frishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02713713_CR1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJM197801052980114","volume":"298","author":"MJ Belman","year":"1978","unstructured":"Belman MJ, Tiep BL, Westinghouse WD (1978) Isoproterenol in pulmonary hypertension. N Engl J Med 298:51","journal-title":"N Engl J Med"},{"key":"BF02713713_CR2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/hrt.38.3.264","volume":"38","author":"PDV Bourdillen","year":"1976","unstructured":"Bourdillen PDV (1976) Regression of primary pulmonary hypertension. Br Heart J 38:264","journal-title":"Br Heart J"},{"key":"BF02713713_CR3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0002-9149(78)90102-9","volume":"42","author":"FS Daoud","year":"1978","unstructured":"Daoud FS, Reeves JT, Kelly DB (1978): Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Am J Cardiol 42:817","journal-title":"Am J Cardiol"},{"key":"BF02713713_CR4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0002-8703(78)90515-X","volume":"95","author":"A Davidson","year":"1978","unstructured":"Davidson A, McMurty I, Reeves JT (1978) Pulmonary vascular effects of verapamil. Am Heart J 95:811","journal-title":"Am Heart J"},{"key":"BF02713713_CR5","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.CIR.56.5.884","volume":"56","author":"WD Edwards","year":"1977","unstructured":"Edwards WD, Edwards JE (1977) Clinical primary pulmonary hypertension: three pathologic types. Circulation 56:884","journal-title":"Circulation"},{"key":"BF02713713_CR6","first-page":"1177","volume":"3","author":"U Elkayam","year":"1978","unstructured":"Elkayam U, Frishman W, Yoran C, Strom J, Cohen M (1978) Unfavorable hemodynamic and clinical effects of isoproterenol therapy in primary pulmonary hypertension. Cardiovasc Med 3:1177","journal-title":"Cardiovasc Med"},{"key":"BF02713713_CR7","unstructured":"Gatewood RP Jr, Yu PN (1979) Primary pulmonary Hypertension. Progress in Cardiology. Lea and Febiger, Philadelphia"},{"key":"BF02713713_CR8","first-page":"53","volume":"22","author":"AM Goff","year":"1969","unstructured":"Goff AM, Gaensler EA (1969) Primary pulmonary hypertension. Med Thorac 22:53","journal-title":"Med Thorac"},{"key":"BF02713713_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0002-8703(61)90510-5","volume":"61","author":"RF Grover","year":"1961","unstructured":"Grover RF, Reeves J, Blount SG (1961) Tolazoline hydrochloride: an effective pulmonary vasodilator. Am Heart J 61:5","journal-title":"Am Heart J"},{"key":"BF02713713_CR10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/hrt.19.2.272","volume":"19","author":"P Harris","year":"1957","unstructured":"Harris P (1957) Influence of acetylcholine on the pulmonary arterial pressure. Br Heart J 19:272","journal-title":"Br Heart J"},{"key":"BF02713713_CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM198001103020204","volume":"302","author":"WP Klinke","year":"1980","unstructured":"Klinke WP, Gilbert JAL (1980) Diazoxide in primary pulmonary hypertension. N Engl J Med 302:91","journal-title":"N Engl J Med"},{"key":"BF02713713_CR12","first-page":"75","volume":"15","author":"E Knapp","year":"1977","unstructured":"Knapp E, Gmeiner R (1977) Reduction of pulmonary hypertension by nitroprusside. Int J Clin Pharmacol Biopharm 15:75","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"BF02713713_CR13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.0954-6820.1978.tb08443.x","volume":"204","author":"K Landmark","year":"1978","unstructured":"Landmark K, Refsum AM, Simonsen S, Storstein O (1978) Verapamil and pulmonary hypertension. Acta Med Scand 204:299","journal-title":"Acta Med Scand"},{"key":"BF02713713_CR14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1378\/chest.74.3.299","volume":"74","author":"Y Nagasaka","year":"1978","unstructured":"Nagasaka Y, Hiroshi A, Yong SL, Fujimoto S, Chikamori J (1978) Long-term favorable effect of oxygen administration on a patient with primary pulmonary hypertension. Chest 74:299","journal-title":"Chest"},{"key":"BF02713713_CR15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1378\/chest.76.5.601","volume":"76","author":"B Person","year":"1979","unstructured":"Person B, Proctor R (1979) Primary pulmonary hypertension: Response to terbutaline and isoproterenol. Chest 76:601","journal-title":"Chest"},{"key":"BF02713713_CR16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1177\/000331977903001105","volume":"30","author":"DE Pittman","year":"1979","unstructured":"Pittman DE (1979) Primary pulmonary hypertension: Case report and discussion of the literature. Angiology 30:756","journal-title":"Angiology"},{"key":"BF02713713_CR17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.CIR.40.4.583","volume":"40","author":"BNS Rao","year":"1969","unstructured":"Rao BNS, Moller JH, Edwards JE (1969) Primary pulmonary hypertension in a child: Response to pharmacologic agents. Circulation 40:583","journal-title":"Circulation"},{"key":"BF02713713_CR18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/cvr\/12.12.752","volume":"12","author":"F Rengo","year":"1978","unstructured":"Rengo F, Trimarco B, Chiariello M (1978) Histamine and hypoxic pulmonary hypertension: A qualitative study. Cardiovasc Res 12:752","journal-title":"Cardiovasc Res"},{"key":"BF02713713_CR19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM198001103020201","volume":"302","author":"LJ Rubin","year":"1978","unstructured":"Rubin LJ, Robert HR (1978) Oral hydralazine therapy for primary pulmonary hypertension. N Engl J Med 302:69","journal-title":"N Engl J Med"},{"key":"BF02713713_CR20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-90-5-772","volume":"90","author":"JN Ruskin","year":"1979","unstructured":"Ruskin JN, Hutter AM Jr (1979) Primary pulmonary hypertension treated with oral phentolamine. Ann Intern Med 90:772","journal-title":"Ann Intern Med"},{"key":"BF02713713_CR21","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJM197612162952506","volume":"295","author":"U Shettigar","year":"1976","unstructured":"Shettigar U, Hultgren HN, Specter M, Martin R, Davies DH (1976) Primary pulmonary hypertension: Favorable effect of isoproterenol. N Engl J Med 295:1414","journal-title":"N Engl J Med"},{"key":"BF02713713_CR22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/01.RES.45.3.360","volume":"45","author":"ED Sivak","year":"1979","unstructured":"Sivak ED et al. (1979) Pulmonary vascular response to nitroprusside. Circ Res 45:360","journal-title":"Circ Res"},{"key":"BF02713713_CR23","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/01.CIR.26.6.1358","volume":"26","author":"JC Sleeper","year":"1962","unstructured":"Sleeper JC, Prgain ES, McIntosh HD (1962) Primary pulmonary hypertension: Review of clinical features and pathologic physiology with a report of pulmonary hemodynamics derived from repeated catheterization. Circulation 26:1358","journal-title":"Circulation"},{"key":"BF02713713_CR24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.0954-6820.1966.tb05449.x","volume":"179","author":"O Storstein","year":"1966","unstructured":"Storstein O, Efskind L, M\u00fcller C, Rokseth R, Sander S (1966) Primary pulmonary hypertension with emphasis on its etiology and treatment. Acta Med Scand 179: 197","journal-title":"Acta Med Scand"},{"key":"BF02713713_CR25","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/hrt.41.6.702","volume":"41","author":"L Suarez","year":"1979","unstructured":"Suarez L (1979) Long-term follow-up in primary pulmonary hypertension. Br Heart J 41:702","journal-title":"Br Heart J"},{"key":"BF02713713_CR26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1136\/hrt.40.12.1397","volume":"40","author":"J Syczedklik","year":"1978","unstructured":"Syczedklik J (1978) Effects of prostaglandin El on the pulmonary circulation in patients with pulmonary hypertension. Br Heart J 40:1397","journal-title":"Br Heart J"},{"key":"BF02713713_CR27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/hrt.40.5.572","volume":"40","author":"S Wang","year":"1978","unstructured":"Wang S (1978) Diazoxide in the treatment of primary pulmonary hypertension. Br Heart J 40:572","journal-title":"Br Heart J"},{"key":"BF02713713_CR28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/hrt.22.4.571","volume":"22","author":"J Widimsky","year":"1960","unstructured":"Widimsky J, Kasalicky J, Valach A, Dejdar R, Vyslovzil Z, Lukes M (1960) Effect of Priscol on the pulmonary circulation in cor pulmonale. Br Heart J 22:571","journal-title":"Br Heart J"},{"key":"BF02713713_CR29","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(60)91854-7","volume":"1","author":"DEL Wilckin","year":"1960","unstructured":"Wilckin DEL, MacKenzie KM, Goodwin JF (1960) Anticoagulation therapy of obliterative pulmonary hypertension. Lancet 1:781","journal-title":"Lancet"},{"key":"BF02713713_CR30","volume-title":"Primary pulmonary hypertension report on a WHO meeting","author":"World Health Organization","year":"1975","unstructured":"World Health Organization (1975) Primary pulmonary hypertension report on a WHO meeting. Hatano S, Strasser T (eds). WHO, Geneva"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02713713.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02713713\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02713713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T01:10:56Z","timestamp":1558228256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02713713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1980,12]]}},"alternative-id":["BF02713713"],"URL":"https:\/\/doi.org\/10.1007\/bf02713713","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[1980,12]]}}}